These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7071947)

  • 21. Attempts to prevent disuse osteoporosis by treatment with calcitonin, longitudinal compression and supplementary calcium and phosphate.
    Hantman DA; Vogel JM; Donaldson CL; Friedman R; Goldsmith RS; Hulley SB
    J Clin Endocrinol Metab; 1973 May; 36(5):845-58. PubMed ID: 4698244
    [No Abstract]   [Full Text] [Related]  

  • 22. Paget's disease of bone: experiences with 100 patients treated with salmon calcitonin.
    Grunstein HS; Clifton-Bligh P; Posen S
    Med J Aust; 1981 Sep; 2(6):278-80. PubMed ID: 7300759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of specific anti-salmon calcitonin antibodies on biological effectiveness of nasal salmon calcitonin in Paget's disease of bone.
    Reginster JY; Gennari C; Mautalen C; Deroisy R; Denis D; Lecart MP; Vandalem JL; Collette J; Franchimont P
    Scand J Rheumatol; 1990; 19(1):83-6. PubMed ID: 2309107
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of calcitonin and hexestrol on urinary excretion of hydroxyproline in a patient with prostatic cancer and bone metastases.
    Matsushita Y; Hasegawa K; Sugimura R; Otomo S; Morii H
    Endocrinol Jpn; 1974 Apr; 21(2):109-13. PubMed ID: 4408206
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prevention of post-ovariectomy osteoporosis in the rat. Comparative study of synthetic salmon calcitonin and eel calcitonin aminosuberic analogue].
    Gnudi S; Zati A; Giardino R; Fini M; Pratelli L; Orlandi M; Figus E
    Minerva Endocrinol; 1993 Sep; 18(3):123-7. PubMed ID: 8183179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Thyrocalcitonin and its clinical use].
    Migunova NA; Nikiforova NV; Ermolenko VM; Briskin AI
    Sov Med; 1973 Apr; 36(4):34-8. PubMed ID: 4588905
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of calcitonin on anastrozole-induced bone pain during aromatase inhibitor therapy for breast cancer.
    Liu P; Yang DQ; Xie F; Zhou B; Liu M
    Genet Mol Res; 2014 Jul; 13(3):5285-91. PubMed ID: 25078584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The value of the calcitonin test in Paget's disease of bone].
    D'Amore M; Bozzi A; Telesca ML; Carrozzo M
    Minerva Med; 1981 Apr; 72(14):865-8. PubMed ID: 7219796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic balance studies in patients with Paget's disease receiving salmon calcitonin over long periods.
    Oreopoulos DG; Husdan H; Harrison J; Meema HE; McNeill KG; Murray TM; Ogilvie R; Rapoport A
    Can Med Assoc J; 1977 Apr; 116(8):851-5. PubMed ID: 856428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salmon calcitonin in prevention of osteoporosis in maintenance dialysis patients.
    Wang SX; Li H
    Chin Med J (Engl); 2008 Jul; 121(14):1280-4. PubMed ID: 18713548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of salmon calcitonin treatment in bone metastases from breast cancer--a controlled trial.
    Blomqvist C; Elomaa I; Porkka L; Karonen SL; Lamberg-Allardt C
    Bone; 1988; 9(1):45-51. PubMed ID: 3288258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salmon and porcine calcitonin treatment of Paget's disease of bone.
    Avramides A
    Clin Orthop Relat Res; 1977; (127):78-85. PubMed ID: 303164
    [No Abstract]   [Full Text] [Related]  

  • 33. Paget's disease of the bone: observations after cessation of long-term synthetic salmon calcitonin treatment.
    Avramides A; Flores A; DeRose J; Wallach S
    J Clin Endocrinol Metab; 1976 Mar; 42(3):459-63. PubMed ID: 1254686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of Paget's disease with calcitonin.
    DeRose J; Avramides A; Baker RK; Wallach S
    Semin Drug Treat; 1972; 2(1):51-5. PubMed ID: 5065517
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of calcitonin in metastatic bone carcinoma, osteoporosis, polyostotic fibrous dysplasia and hypercalcemia.
    Morii H; Tanae A; Ibayashi H; Nakao K
    Endocrinol Jpn; 1971 Feb; 17(6):81-90. PubMed ID: 4254451
    [No Abstract]   [Full Text] [Related]  

  • 36. Hereditary bone dysplasia with hyperphosphatasaemia: response to synthetic human calcitonin.
    Horwith M; Nunez EA; Krook L; Viteri F; Torun B; Mena E; Suh SM; Eisenberg E; MacIntyre I; Whalen JP
    Clin Endocrinol (Oxf); 1976; 5 Suppl():341S-352S. PubMed ID: 1052783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salmon-calcitonin nasal spray in Paget's disease of bone: preliminary results in five patients.
    Reginster JY; Albert A; Franchimont P
    Calcif Tissue Int; 1985 Dec; 37(6):577-80. PubMed ID: 3937575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Calcitonin nasal spray for Paget's disease of the bone].
    Luboshitzky R; Bar-Shalom R
    Harefuah; 1995 Mar; 128(6):358-62, 399. PubMed ID: 7750816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of Paget's disease of bone with synthetic salmon calcitonin.
    Kanis JA; Horn DB; Scott RD; Strong JA
    Br Med J; 1974 Sep; 3(5933):727-31. PubMed ID: 4472416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Densitometric analysis in in vivo evaluation of synthetic salmon calcitonin activity.
    Gnudi S; Mongiorgi R; Moroni A; Bertocchi G
    J Clin Pharm Ther; 1988 Apr; 13(2):125-30. PubMed ID: 3392126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.